These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31930636)

  • 41. Medicare Part D payments for neurologist-prescribed drugs.
    De Lott LB; Burke JF; Kerber KA; Skolarus LE; Callaghan BC
    Neurology; 2016 Apr; 86(16):1491-8. PubMed ID: 27009256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study.
    Norris SL; Holmer HK; Ogden LA; Burda BU; Fu R
    BMC Med Ethics; 2012 Sep; 13():24. PubMed ID: 23013260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trust and transparency: patient perceptions of physicians' financial relationships with pharmaceutical companies.
    Perry JE; Cox D; Cox AD
    J Law Med Ethics; 2014; 42(4):475-91. PubMed ID: 25565614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promotional Payments Made to Urologists by the Pharmaceutical Industry and Prescribing Patterns for Targeted Therapies.
    Hollenbeck BK; Oerline M; Kaufman SR; Caram MEV; Dusetzina SB; Ryan AM; Shahinian VB
    Urology; 2021 Feb; 148():134-140. PubMed ID: 33075381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough.
    Lexchin J; Fugh-Berman A
    J Gen Intern Med; 2021 Oct; 36(10):3194-3198. PubMed ID: 33694070
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018.
    Nalleballe K; Sheng S; Li C; Mahashabde R; Annapureddy AR; Mudassar K; Pothineni K; Veerapaneni P; Harada Y; Chilkulwar A; Ranabothu S; Brown A; Kapoor N; Onteddu S
    Stroke; 2020 Apr; 51(4):1339-1343. PubMed ID: 32078482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? : A Systematic Review.
    Mitchell AP; Trivedi NU; Gennarelli RL; Chimonas S; Tabatabai SM; Goldberg J; Diaz LA; Korenstein D
    Ann Intern Med; 2021 Mar; 174(3):353-361. PubMed ID: 33226858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonresearch Pharmaceutical Industry Payments to Oncology Physician Editors.
    Haque W; Alvarenga M; Hsiehchen D
    Oncologist; 2020 Jun; 25(6):e986-e989. PubMed ID: 32272494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of non-research payments from pharmaceutical companies to urologists in Japan between 2016 and 2019.
    Murayama A; Saito H; Kamamoto S; Shigeta H; Yamashita E; Tanimoto T; Ozaki A
    Int Urogynecol J; 2023 Jun; 34(6):1285-1292. PubMed ID: 36723634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between industry payments for opioid products and physicians' prescription of opioids: observational study with propensity-score matching.
    Inoue K; Figueroa JF; Orav EJ; Tsugawa Y
    J Epidemiol Community Health; 2020 Aug; 74(8):647-654. PubMed ID: 32350126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Associations Between Industry Payments to Physicians for Antiplatelet Drugs and Utilization of Cardiac Procedures and Stents.
    Yanagisawa M; Blumenthal DM; Kato H; Inoue K; Tsugawa Y
    J Gen Intern Med; 2022 May; 37(7):1626-1633. PubMed ID: 34378113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
    Fickweiler F; Fickweiler W; Urbach E
    BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States.
    Inoue K; Figueroa JF; DeJong C; Tsugawa Y; Orav EJ; Shen C; Kazi DS
    Circ Cardiovasc Qual Outcomes; 2021 May; 14(5):e007521. PubMed ID: 33966446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tip of the Iceberg? Country- and Company-Level Analysis of Drug Company Payments for Research and Development in Europe.
    Ozieranski P; Martinon L; Jachiet PA; Mulinari S
    Int J Health Policy Manag; 2022 Dec; 11(12):2842-2859. PubMed ID: 35297231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physician-Industry Interactions and Anti-Vascular Endothelial Growth Factor Use Among US Ophthalmologists.
    Taylor SC; Huecker JB; Gordon MO; Vollman DE; Apte RS
    JAMA Ophthalmol; 2016 Aug; 134(8):897-903. PubMed ID: 27356110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of current financial relationships between emergency physicians and industry.
    Niforatos JD; Boas S; Hertz S; Ozgur A; Raja AS
    Am J Emerg Med; 2019 Apr; 37(4):722-725. PubMed ID: 30611579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey.
    Pham-Kanter G; Mello MM; Lehmann LS; Campbell EG; Carpenter D
    J Gen Intern Med; 2017 Jul; 32(7):767-774. PubMed ID: 28265803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oversight of marketing relationships between physicians and the drug and device industry: a comparative study.
    Jost TS
    Am J Law Med; 2010; 36(2-3):326-42. PubMed ID: 20726399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Financial relationships between neurologists and industry: The 2015 Open Payments database.
    Ahlawat A; Narayanaswami P
    Neurology; 2019 May; 92(21):1006-1013. PubMed ID: 31110144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-sectional analysis of open payments for physicians at designated hemophilia centers in the US (2018-2020).
    Haslam A; Prasad V
    Thromb Res; 2023 Jul; 227():40-44. PubMed ID: 37210957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.